Mal-(CH2)5-Val-Cit-PAB-Eribulin, CAS 2130869-21-3

Product Description: Mal-(CH2)5-Val-Cit-PAB-Eribulin is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-microtubule agent, Eribulin, linked via linker Mal-(CH2)5-Val-Cit-PAB[1].

Applications: Cancer-programmed cell death

Formula: C69H97N7O19

References: [1]Earl F Albone, et al. Eribulin-based antibody-drug conjugates and methods of use. Patent US20170252458A1./[2]Watanabe K, et, al. Low-dose eribulin reduces lung metastasis of osteosarcoma in vitro and in vivo. Oncotarget. 2019 Jan 4; 10(2): 161-174.

CAS Number: 2130869-21-3

Molecular Weight: 1328.54

Compound Purity: 99.82

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Drug-Linker Conjugates for ADC

• Artikelnummer: MEXHY-139642-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-139642-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK